Data / Form D filings / Goodwin Biotechnology, Inc
Goodwin Biotechnology, Inc: Form D filings
Goodwin Biotechnology, Inc, a health care company in Plantation, FL, filed 4 Form D notices with the SEC between 2019 and 2026. The latest, on January 27, 2026, reports $2 million sold of a $4 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1850 NW 69TH AVENUE, SUITE 4, Plantation, FL, 33313
- Phone
- (954) 321-5300
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b), Securities Act section 4(a)(5)
- SEC identifier (CIK)
- 1774572
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 27, 2026 | New notice | $4,000,000 | $2,000,000 | $2,000,000 | 2 | Dec 5, 2025 | sec.gov |
| Nov 12, 2024 | New notice | $3,000,000 | $3,000,000 | 1 | Nov 1, 2024 | sec.gov | |
| Oct 2, 2023 | New notice | $5,000,002 | $5,000,002 | 3 | Sep 12, 2023 | sec.gov | |
| Apr 30, 2019 | New notice | $20,725,000 | $20,725,000 | 5 | Apr 18, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Karl Pinto | Executive Officer, Director | |
| Nikhil Puri | Director | |
| Divya Menezes | Director | |
| Kent Payne | Director | |
| Brandon Price | Director | |
| Steven Vorgity | Executive Officer |
Other health care companies in Florida that filed recently
- Lev 18, Inc. $250,000 · Oct 9, 2026
- Coast Medical Innovations, LLC $550,000 · Oct 8, 2026
- Metabolica, Inc. offering · Oct 7, 2026
- Colonial Outpatient Surgery Center, LLC $915,156 · Sep 30, 2026
- VIRGO CAPITAL PARTNERS, LLC offering · Sep 17, 2026
- Prosper Health, Inc. $10 million · Sep 10, 2026
Every Form D from the week of Jan 26, 2026 · All recent filings in Florida · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Goodwin Biotechnology, Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.